News

Announcing our new NCI-funded project with Google and SRA International: The Cancer Genomics Cloud

We are very excited to start on an a new, NCI-funded project with partners Google and SRA International, to develop a cloud based platform — the Cancer Genomics Cloud (CGC) — to enable cancer genomics research at unprecedented scale.

Read More

mittechreviewlogo1-w320h2401-w320h240

genomeWeb_logo
http://www.genomeweb.com/informatics/nci-contracts-isb-google-sra-team-develop-infrastructure-cancer-genomics-cloud-p

biotechit
http://www.fiercebiotechit.com/story/isb-teams-google-nci-cancer-genomics-cloud-project/2014-10-13

nbc
http://www.nbcnews.com/tech/innovation/google-teams-put-cancer-genome-research-cloud-n226681

Recent Articles

  • Cultivated meat illustration

    How Systems Biology Is Helping Advance the Cultivated Meat Industry

    The quest to create cultivated meat has been a true multidisciplinary puzzle. It’s biology, engineering, physics, bioinformatics, mathematics, computer science, and more. Enter systems biology. ISB and other organizations are toiling to better understand how to create lab-grown meat in a safe, effective manner that can eventually scale up to compete with traditional meat.

  • 2021 Innovator Awards

    Three Collaborative Projects Announced for ISB’s 2021 Innovator Award Program

    ISB has kicked off the fifth year of its Innovator Award Program by announcing three collaborative and cross-disciplinary projects. The program was created in 2017 to support early-career scientists working on high-risk, high-reward innovations, and champions interdisciplinary collaboration for non-faculty ISB researchers.

  • CRI iAtlas

    CRI iAtlas Expands to Interactive Analysis of Data on Immunotherapy Treatments

    CRI iAtlas is a comprehensive web-based resource that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment. The iAtlas team released immuno-oncology modules that allow investigators to access and work with genomics data from trials of treatment with immune-checkpoint inhibitors.